121 related articles for article (PubMed ID: 9498539)
1. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.
Mahaffey KW; Granger CB; Sloan MA; Thompson TD; Gore JM; Weaver WD; White HD; Simoons ML; Barbash GI; Topol EJ; Califf RM
Circulation; 1998 Mar; 97(8):757-64. PubMed ID: 9498539
[TBL] [Abstract][Full Text] [Related]
2. Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
Mahaffey KW; Harrington RA; Simoons ML; Granger CB; Graffagnino C; Alberts MJ; Laskowitz DT; Miller JM; Sloan MA; Berdan LG; MacAulay CM; Lincoff AM; Deckers J; Topol EJ; Califf RM
Circulation; 1999 May; 99(18):2371-7. PubMed ID: 10318656
[TBL] [Abstract][Full Text] [Related]
3. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
[TBL] [Abstract][Full Text] [Related]
4. Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis.
O'Connor CM; Califf RM; Massey EW; Mark DB; Kereiakes DJ; Candela RJ; Abbottsmith C; George B; Stack RS; Aronson L
J Am Coll Cardiol; 1990 Sep; 16(3):533-40. PubMed ID: 2117618
[TBL] [Abstract][Full Text] [Related]
5. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
Gore JM; Granger CB; Simoons ML; Sloan MA; Weaver WD; White HD; Barbash GI; Van de Werf F; Aylward PE; Topol EJ
Circulation; 1995 Nov; 92(10):2811-8. PubMed ID: 7586246
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
7. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study.
White HD; Barbash GI; Modan M; Simes J; Diaz R; Hampton JR; Heikkilä J; Kristinsson A; Moulopoulos S; Paolasso EA
Circulation; 1993 Nov; 88(5 Pt 1):2097-103. PubMed ID: 8222103
[TBL] [Abstract][Full Text] [Related]
8. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group.
Tanne D; Goldbourt U; Zion M; Reicher-Reiss H; Kaplinsky E; Behar S
Stroke; 1993 Oct; 24(10):1490-5. PubMed ID: 8378952
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
[TBL] [Abstract][Full Text] [Related]
10. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators.
Lee KL; Woodlief LH; Topol EJ; Weaver WD; Betriu A; Col J; Simoons M; Aylward P; Van de Werf F; Califf RM
Circulation; 1995 Mar; 91(6):1659-68. PubMed ID: 7882472
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era: the Israeli Thrombolytic National Survey.
Tanne D; Gottlieb S; Caspi A; Hod H; Palant A; Reisin L; Rosenfeld T; Peled B; Marmor AT; Balkin J; Boyko V; Behar S
Arch Intern Med; 1998 Mar; 158(6):601-6. PubMed ID: 9521224
[TBL] [Abstract][Full Text] [Related]
12. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.
Crenshaw BS; Granger CB; Birnbaum Y; Pieper KS; Morris DC; Kleiman NS; Vahanian A; Califf RM; Topol EJ
Circulation; 2000 Jan 4-11; 101(1):27-32. PubMed ID: 10618300
[TBL] [Abstract][Full Text] [Related]
13. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
[TBL] [Abstract][Full Text] [Related]
14. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
15. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
[TBL] [Abstract][Full Text] [Related]
16. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Sloan MA; Sila CA; Mahaffey KW; Granger CB; Longstreth WT; Koudstaal P; White HD; Gore JM; Simoons ML; Weaver WD; Green CL; Topol EJ; Califf RM
Circulation; 1998 Oct; 98(14):1376-82. PubMed ID: 9760291
[TBL] [Abstract][Full Text] [Related]
17. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
[TBL] [Abstract][Full Text] [Related]
18. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
Tung CY; Granger CB; Sloan MA; Topol EJ; Knight JD; Weaver WD; Mahaffey KW; White H; Clapp-Channing N; Simoons ML; Gore JM; Califf RM; Mark DB
Circulation; 1999 Jan; 99(3):370-6. PubMed ID: 9918523
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
Singh M; White J; Hasdai D; Hodgson PK; Berger PB; Topol EJ; Califf RM; Holmes DR
J Am Coll Cardiol; 2007 Oct; 50(18):1752-8. PubMed ID: 17964038
[TBL] [Abstract][Full Text] [Related]
20. Is it clinically possible to distinguish nonhemorrhagic infarct from hemorrhagic stroke?
Besson G; Robert C; Hommel M; Perret J
Stroke; 1995 Jul; 26(7):1205-9. PubMed ID: 7604415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
